Stayble Therapeutics presents at ProHearings Capital Market Day on December 1 2022
On Thursday, December 1, Stayble Therapeutics AB ("Stayble" or the "Company") will participate in ProHearing's investor event. The Company's CEO, Andreas Gerward, will give an investor presentation and answer questions in a moderated Q&A session following the presentation.The presentation and Q&A session will be broadcast live via a link at www.prohearings.com, where you can also register to attend the event in person. Questions can be sent to the moderator by emailing info@prohearings.com. After the event, the presentation will be available on our website https://staybletherapeutics.com/.